Abstract Search

ea0034p117 | Clinical practice/governance and case reports | SFEBES2014

Polycythaemia is a common side-effect of testosterone therapy, regardless of treatment mode, and careful monitoring of haematological indices is required

Bhatti Rahila , Grimmett Belinda , McCarthy Maeve , Agusttson Tomas , McGowan Barbara , Powrie Jake , Carroll Paul

Background: Testosterone replacement is the mainstay of treatment for male hypogonadism. The most commonly reported adverse event in testosterone trials is polycythaemia. This study assessed the prevalence of polycythaemia in males receiving testosterone replacement and compared prevalence rates between different treatment preparations.Methods: 216 men were included in this retrospective observational study conducted from January 2009 to December 2012. 1...

0 shares

Endocrine Abstracts

Polycythaemia is a common side-effect of testosterone therapy, regardless of treatment mode, and careful monitoring of haematological indices is required

BiosciAbstracts